415 related articles for article (PubMed ID: 20828919)
1. Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials.
Bex A; Jonasch E; Kirkali Z; Mejean A; Mulders P; Oudard S; Patard JJ; Powles T; van Poppel H; Wood CG
Eur Urol; 2010 Dec; 58(6):819-28. PubMed ID: 20828919
[TBL] [Abstract][Full Text] [Related]
2. Integrating surgery with targeted therapies for renal cell carcinoma: maximizing benefits, minimizing risk.
Clarke NW
Eur Urol; 2010 Dec; 58(6):829-30. PubMed ID: 20934244
[No Abstract] [Full Text] [Related]
3. Neoadjuvant and adjuvant strategies in renal cell carcinoma: more questions than answers.
Homicsko K; Berthold DR
Anticancer Drugs; 2011 Jan; 22 Suppl 1():S4-8. PubMed ID: 21173604
[TBL] [Abstract][Full Text] [Related]
4. Surgery for renal cell carcinoma metastases.
Breau RH; Blute ML
Curr Opin Urol; 2010 Sep; 20(5):375-81. PubMed ID: 20592612
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant and adjuvant treatment of renal cell carcinoma.
Thillai K; Allan S; Powles T; Rudman S; Chowdhury S
Expert Rev Anticancer Ther; 2012 Jun; 12(6):765-76. PubMed ID: 22716493
[TBL] [Abstract][Full Text] [Related]
6. High-dose interleukin-2 in metastatic renal cell carcinoma.
Fernández-Rodríguez R; de Argumedo GL; Mañé JM; Muñoz A; Ferreiro J; Fuente N; López-Vivanco G
J Clin Oncol; 2005 Sep; 23(27):6797-8; author reply 6798-9. PubMed ID: 16170190
[No Abstract] [Full Text] [Related]
7. Vaccine therapy in patients with renal cell carcinoma.
Van Poppel H; Joniau S; Van Gool SW
Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
[TBL] [Abstract][Full Text] [Related]
8. Current clinical trials in renal cell carcinoma.
Sokoloff MH; Daneshmand S; Ryan CW
Urol Oncol; 2005; 23(4):289-92. PubMed ID: 16018946
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant and neoadjuvant therapy for renal cell carcinoma: a survey of the Society of Urologic Oncology.
Tobert CM; Uzzo RG; Wood CG; Lane BR
Urol Oncol; 2013 Oct; 31(7):1316-20. PubMed ID: 22264501
[TBL] [Abstract][Full Text] [Related]
10. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome.
Wood CG
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):697s-702s. PubMed ID: 17255296
[TBL] [Abstract][Full Text] [Related]
11. Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors.
Chan HY; Grossman AB; Bukowski RM
Adv Ther; 2010 Aug; 27(8):495-511. PubMed ID: 20623346
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of renal cell carcinoma in children: a report from the Polish pediatric rare tumor study group.
Stachowicz-Stencel T; Bien E; Balcerska A; Godzinski J; Synakiewicz A; Perek-Polnik M; Kurylak A; Pietras W; Kuzmicz M; Mizia-Malarz A; Rybczynska A; Nurzynska-Flak J
Klin Padiatr; 2011 May; 223(3):138-41. PubMed ID: 21509711
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant (presurgical) therapy for renal cell carcinoma: a new treatment paradigm for locally advanced and metastatic disease.
Wood CG; Margulis V
Cancer; 2009 May; 115(10 Suppl):2355-60. PubMed ID: 19402066
[TBL] [Abstract][Full Text] [Related]
14. The role of cytoreductive nephrectomy in the era of molecular targeted therapy.
Polcari AJ; Gorbonos A; Milner JE; Flanigan RC
Int J Urol; 2009 Mar; 16(3):227-33. PubMed ID: 19207114
[TBL] [Abstract][Full Text] [Related]
15. Impact of lymph node invasion and sarcomatoid differentiation on the survival of patients with locally advanced renal cell carcinoma.
Rodríguez-Covarrubias F; Castillejos-Molina R; Sotomayor M; Méndez-Probst CE; Gómez-Alvarado MO; Uribe-Uribe N; Gabilondo F; Feria-Bernal G
Urol Int; 2010; 85(1):23-9. PubMed ID: 20693824
[TBL] [Abstract][Full Text] [Related]
16. Is tumor response important for renal carcinoma?
Inman BA; George DJ
Eur Urol; 2011 Jan; 59(1):16-7. PubMed ID: 20970245
[No Abstract] [Full Text] [Related]
17. Novel targeted therapy for advanced renal carcinoma: trials in progress.
Calabrò F; Sternberg CN
Curr Opin Urol; 2010 Sep; 20(5):382-7. PubMed ID: 20625300
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapy of renal cell cancer.
Wysocki PJ; Zolnierek J; Szczylik C; Mackiewicz A
Curr Opin Investig Drugs; 2008 Jun; 9(6):570-5. PubMed ID: 18516756
[TBL] [Abstract][Full Text] [Related]
19. Integration of surgery and systemic therapy for renal cell carcinoma.
Kenney PA; Wood CG
Urol Clin North Am; 2012 May; 39(2):211-31, vii. PubMed ID: 22487764
[TBL] [Abstract][Full Text] [Related]
20. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]